// App-Quantinova.ai

14565 2014 BOS : ABCA1 Ligand Peptides That Stimulate Cellular Cholesterol Efflux With High Potency Increase Insulin Sensitivity in Metabolic and Genetic Mouse Models of Obesity and Type 2 Diabetes

Researchers

Presenter

  • Stefanie Bittner

Principal Investigators

  • Juveria Tabassum

  • Anouar Hafiane

  • Jacques Genest

  • Salman Azhar

  • Jan Johansson

Medical Centers

  • Artery Therapeutics, San Ramon, CA

  • Stanford Univ, Palo Alto, CA

  • McGill, Montreal, QC, Canada

  • Lawrence Berkeley National Lab, Berkeley, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Coronary Artery Disease

  • Diabetes

  • Obesity

Biomarkers

  • Cholesterol

  • C-peptide

  • Insulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved